Skip to main content
Top

Cancer and Metastasis Reviews

Issue 1/2005

Content (13 Articles)

Preface

József Tímár

Human papillomavirus in head and neck cancer: Molecular biology and clinicopathological correlations

Zoltán Szentirmay, Károly Pólus, László Tamás, Gabriella Szentkuti, Judit Kurcsics, Erzsébet Csernák, Erika Tóth, Miklós Kásler

Tumor cell invasion and survival in head and neck cancer

Randall H. Kramer, Xiaodong Shen, Hua Zhou

Biological significance of c-erbB family oncogenes in head and neck cancer

Susanne J. Rogers, Kevin J. Harrington, Peter Rhys-Evans, Pornchai O-Charoenrat, Suzanne A. Eccles

Molecular markers for diagnosis and prognosis

Max Partridge, Kamis Gaballah, Xiaohong Huang

Progression of head and neck squamous cell cancer

József Tímár, Orsolya Csuka, Éva Remenár, Gábor Répássy, Miklós Kásler

Gene therapy for head and neck cancer

Kevin J. Harrington, Christopher M. Nutting, Hardev S. Pandha

The role of B-RAF in melanoma

Vanessa C. Gray-Schopfer, Silvy da Rocha Dias, Richard Marais

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine